EP Patent

EP1295609A4 — DRUGS CONTAINING COMBINED ACTIVE INGREDIENTS

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2004-11-03 · 22y expired

What this patent protects

Drugs containing, as the active ingredients, exclusively a combination of an α-glucosidase inhibitor with a non-sulfonylurea insulin secretion promoter which are useful as preventives and remedies for diabetes, etc.

USPTO Abstract

Drugs containing, as the active ingredients, exclusively a combination of an α-glucosidase inhibitor with a non-sulfonylurea insulin secretion promoter which are useful as preventives and remedies for diabetes, etc.

Drugs covered by this patent

Patent Metadata

Patent number
EP1295609A4
Jurisdiction
EP
Classification
—
Expires
2004-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.